Kato N, March S, Bhatia SN, Marti M. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages. Methods Mol Biol. 2018;1787:41-52. doi:10.1007/978-1-4939-7847-2_3
Dimova D, Wawer M, Wassermann AM, Bajorath J. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. J Chem Inf Model. 2011;51(2):258-66. doi:10.1021/ci100477m
Camacho DM, Collins KM, Powers RK, Costello JC, Collins JJ. Next-Generation Machine Learning for Biological Networks. Cell. 2018;173(7):1581-1592. doi:10.1016/j.cell.2018.05.015
Watmuff B, Liu B, Karmacharya R. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder. Pharmacogenomics. 2017;18(5):471-479. doi:10.2217/pgs-2016-0187
Kulesa A, Kehe J, Hurtado JE, Tawde P, Blainey PC. Combinatorial drug discovery in nanoliter droplets. Proc Natl Acad Sci U S A. 2018;115(26):6685-6690. doi:10.1073/pnas.1802233115
Okoli I, Coleman JJ, Tampakakis E, et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One. 2009;4(9):e7025. doi:10.1371/journal.pone.0007025
Sharifnia T, Hong AL, Painter CA, Boehm JS. Emerging Opportunities for Target Discovery in Rare Cancers. Cell Chem Biol. 2017;24(9):1075-1091. doi:10.1016/j.chembiol.2017.08.002
Ahfeldt T, Litterman NK, Rubin LL. Studying human disease using human neurons. Brain Res. 2017;1656:40-48. doi:10.1016/j.brainres.2016.03.051
Brennand KJ, Marchetto C, Benvenisty N, et al. Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. Stem Cell Reports. 2015;5(6):933-945. doi:10.1016/j.stemcr.2015.10.011
Marder SR, Roth B, Sullivan PF, et al. Advancing drug discovery for schizophrenia. Ann N Y Acad Sci. 2011;1236:30-43. doi:10.1111/j.1749-6632.2011.06216.x